impact
viral
coinfect
recent
discov
virus
epidemiolog
respiratori
infect
children
still
unclear
simultan
detect
virus
involv
aetiolog
respiratori
infect
use
dnarna
microarray
assay
identifi
differ
virus
viral
subtyp
rhinopharyng
wash
taken
children
age
month
year
present
emerg
depart
respiratori
infect
june
june
treat
outpati
hospit
lower
respiratori
tract
infect
diagnos
often
hospit
children
versu
p
children
microarray
detect
viral
infect
singl
viru
found
two
virus
preval
virus
among
children
posit
sampl
respiratori
syncyti
viru
rsv
parainfluenza
viru
piv
rhinoviru
rv
follow
influenza
adenovirus
bocaviru
human
metapneumoviru
enterovirus
common
viral
coinfect
rsvarsvb
children
rsvinfluenza
rsvrv
pivrv
multipl
logist
regress
analysi
reveal
viral
coinfect
associ
increas
probabl
hospit
ci
p
previou
pneumococc
vaccin
associ
decreas
probabl
hospit
ci
p
conclud
viral
coinfect
involv
signific
proport
children
acut
respiratori
infect
may
increas
sever
clinic
present
risk
hospit
respiratori
infect
repres
major
public
health
problem
high
incid
eas
spread
commun
acut
respiratori
tract
infect
arti
associ
signific
morbid
commonest
reason
outpati
visit
hospit
among
young
children
virus
lead
caus
arti
epidemiolog
variabl
depend
climat
season
region
viral
aetiolog
still
unclear
signific
proport
arti
role
viral
coinfect
controversi
past
decad
new
respiratori
virus
human
metapneumoviru
human
bocaviru
discov
impact
virus
global
epidemiolog
arti
fulli
elucid
moreov
human
rhinovirus
enterovirus
previous
identifi
childhood
upper
respiratori
tract
infect
suspect
major
aetiolog
agent
lower
respiratori
tract
infect
like
bronchiol
pneumonia
infant
viral
respiratori
diagnosi
tradit
reli
antigen
detect
viru
isol
lack
sensit
antigen
detect
delay
result
viru
isol
limit
detect
cultiv
virus
usual
made
diagnosi
respiratori
virus
incomplet
detect
identif
viral
respiratori
agent
howev
improv
last
decad
result
new
molecular
techniqu
molecular
technolog
increas
sensit
accuraci
develop
multiplex
amplif
make
possibl
detect
broad
panel
virus
simultan
inde
use
revers
transcript
rt
pcr
dnarna
microarray
system
allow
rapid
accur
detect
convent
newli
discov
viral
respiratori
pathogen
paediatr
patient
purpos
studi
investig
role
viral
coinfect
arti
examin
possibl
differ
aetiolog
clinic
featur
epidemiolog
infect
nonhospit
hospit
children
use
dnarna
microarray
assay
prospect
studi
respiratori
tract
infect
children
perform
first
depart
paediatr
univers
athen
aghia
sophia
children
hospit
studi
popul
includ
children
age
month
year
present
emerg
depart
symptom
arti
treat
outpati
hospit
june
june
children
hospit
basi
clinic
sever
determin
judgement
attend
physician
demograph
clinic
data
nasopharyng
wash
taken
outpati
children
emerg
depart
hospit
children
sampl
taken
time
admiss
exclud
hospitalacquir
infect
clinic
data
taken
hospit
abstract
medic
record
children
chronic
heart
liver
kidney
diseas
cystic
fibrosi
diabet
report
children
chronic
health
problem
children
least
one
dose
conjug
pneumococc
vaccin
regard
vaccin
arti
classifi
three
categori
upper
respiratori
tract
infect
urti
diagnos
rhiniti
pharyng
laryng
otiti
media
present
absenc
lower
respiratori
tract
infect
lrti
sign
ii
lrti
diagnos
presenc
sign
lower
airway
involv
tachypnoea
dyspnoea
wheez
rale
posit
chest
xray
absenc
urti
iii
urti
plu
lrti
diagnos
sign
symptom
upper
lower
respiratori
tract
laryngotracheobronch
rhiniti
wheez
etc
studi
approv
hospit
ethic
committe
nasopharyng
sampl
collect
inform
consent
obtain
children
parent
assent
given
children
sampl
test
use
rtpcr
dnarna
microarray
system
clart
pneumovir
dna
array
assay
genomica
coslada
madrid
spain
depart
cytopatholog
univers
hospit
attikon
nasopharyng
lavag
sampl
obtain
child
use
standard
procedur
respiratori
specimen
taken
introduc
ml
steril
salin
solut
nasal
fossa
maintain
patient
head
leant
backward
collect
solut
steril
contain
place
nasal
fossa
inclin
patient
head
sampl
store
process
accord
manufactur
instruct
detect
base
amplif
specif
fragment
viral
genom
use
rtpcr
amplif
specif
fragment
viral
genom
rtpcrpcr
amplif
amplifi
product
label
biotin
follow
amplif
hybrid
specif
probe
immobil
site
microarray
incub
streptavidinperoxidas
conjug
addit
tetramethylbenzidin
induc
appear
insolubl
product
precipit
hybrid
site
microarray
result
process
microarray
reader
use
specif
softwar
provid
manufactur
allow
automat
detect
interpret
result
give
full
specif
diagnosi
analysi
report
initi
descript
statist
data
calcul
possibl
associ
hospit
examin
variabl
univari
test
use
chisquar
wilcoxon
test
next
step
multivari
analysi
also
perform
multipl
logist
regress
analysi
hospit
statu
consid
depend
variabl
age
categor
three
categori
baselin
month
sex
categor
baselin
boy
famili
member
respiratori
viral
infect
categor
baselin
chronic
health
problem
categor
baselin
number
wheez
episod
per
year
order
increment
two
episod
fever
present
categor
baselin
bronchodil
use
present
categor
baselin
antibiot
use
present
categor
baselin
influenza
vaccin
categor
baselin
pneumococc
vaccin
least
one
dose
categor
baselin
potenti
confound
final
viral
coinfect
also
introduc
model
addit
variabl
categor
baselin
statist
analysi
perform
sa
version
children
demograph
clinic
characterist
accord
hospit
statu
present
tabl
total
children
boy
arti
includ
studi
hospit
treat
outpati
median
age
month
iqr
hospit
children
younger
p
urti
diagnos
children
lrti
urti
plu
lrti
hospit
children
often
diagnos
lrti
p
chronic
health
problem
p
posit
histori
previou
wheez
episod
p
use
bronchodil
present
p
less
vaccin
pneumococcu
p
fig
differ
distribut
virus
nonhospit
hospit
children
except
rsv
infect
detect
frequent
latter
p
logist
regress
analysi
show
presenc
viral
coinfect
increas
risk
hospit
ci
p
analysi
perform
children
test
posit
least
broaden
viral
diagnosi
respiratori
tract
infect
may
help
clinician
decreas
unnecessari
prescript
antibiot
implement
earli
antivir
treatment
avail
prevent
viru
transmiss
present
studi
use
dnarna
microarray
assay
allow
detect
identif
simultan
type
common
newli
discov
human
virus
method
versatil
greatli
expand
spectrum
detect
virus
singl
assay
simultan
allow
discrimin
among
viral
subtyp
best
knowledg
largest
seri
children
studi
prospect
aim
detect
singl
multipl
respiratori
viral
infect
microarray
technolog
studi
evalu
use
microarray
detect
multipl
respiratori
virus
children
detect
rate
studi
depend
clinic
syndrom
assay
use
similar
studi
one
drawback
viru
detect
genet
amplif
fals
neg
mainli
result
poor
qualiti
extract
dnarna
caus
insuffici
quantiti
initi
sampl
degrad
viru
genet
materi
inadequ
storag
sampl
loss
extract
presenc
inhibitor
enzym
mixtur
revers
transcriptas
dna
polymeras
sampl
viru
detect
go
perform
sputum
respiratori
secret
etc
anoth
possibl
explan
nevertheless
assay
use
studi
elimin
fals
neg
addit
intern
control
extract
along
possibl
virus
present
sampl
subsequ
amplifi
reaction
tube
confirm
correct
effici
extract
pcr
amplif
studi
signific
proport
viral
coinfect
detect
among
children
posit
sampl
associ
increas
possibl
hospit
preval
coinfect
studi
rang
children
seen
hospit
emerg
depart
divers
type
respiratori
tract
infect
detect
method
conflict
result
whether
multipl
viral
infect
associ
sever
clinic
present
compar
singl
infect
sempl
et
al
report
tenfold
increas
rel
risk
admiss
paediatr
intensivecar
unit
mechan
ventil
caus
sever
bronchiol
patient
dual
infect
hmpv
rsv
paranhosbaccala
et
al
show
presenc
one
pathogen
moreov
associ
rsv
rhinovirus
hmpv
might
influenc
natur
cours
bronchiol
research
found
children
hmpvrsv
coinfect
like
develop
pneumonia
manifest
increas
diseas
sever
defin
durat
hospit
need
oxygen
supplement
contrast
investig
fail
demonstr
seriou
diseas
dual
infect
detect
multipl
virus
rais
question
virus
detect
respons
clinic
symptom
innoc
bystand
multipl
virus
success
infect
molecular
test
could
detect
persist
genom
absenc
viral
activ
dna
microarray
assay
employ
qualit
techniqu
abl
identifi
predomin
viral
agent
could
consid
caus
acut
respiratori
syndrom
quantit
pcr
method
probabl
better
tool
discrimin
activ
viru
prolong
presenc
previou
virus
interestingli
pneumococc
vaccin
associ
decreas
probabl
hospit
pneumococc
interact
viral
pathogen
well
establish
increas
clinic
sever
respiratori
infect
present
studi
limit
last
year
virus
differ
circul
commun
consecut
year
moreov
quantif
viral
load
detect
bacteri
coinfect
specif
microarray
assay
use
limit
publish
clinic
valid
especi
paediatr
popul
signific
number
rsvarsvb
coinfect
detect
need
explor
specif
rtpcr
assay
confirm
specif
assay
viral
subtyp
addit
assay
may
underestim
presenc
virus
like
coronavirus
detect
coronaviru
subtyp
signific
proport
children
present
symptom
respiratori
infect
viral
bacteri
pathogen
detect
convent
molecular
method
impli
either
molecular
method
need
improv
sensit
still
virus
discov
issu
associ
viral
coinfect
sever
clinic
present
remain
controversi
compel
need
perform
multicentr
studi
common
protocol
last
sever
year
measur
viral
load
differ
virus
coinfect
comparison
viral
detect
control
group
asymptomat
children
may
help
understand
virus
innoc
rhinopharyng
colon
conclus
studi
viral
coinfect
children
respiratori
tract
infect
increas
risk
hospit
simultan
detect
respiratori
pathogen
microarray
may
elucid
interplay
virus
bacteria
host
may
determin
viral
pathogen
affect
clinic
sever
respiratori
infect
